BRPI0819189A2 - Uso de um gestagênio em combinação com estrogênio e um ou mais excipientes/veículos farmaceuticamente aceitáveis para a contracepção oral livre de lactose. - Google Patents

Uso de um gestagênio em combinação com estrogênio e um ou mais excipientes/veículos farmaceuticamente aceitáveis para a contracepção oral livre de lactose.

Info

Publication number
BRPI0819189A2
BRPI0819189A2 BRPI0819189-1A BRPI0819189A BRPI0819189A2 BR PI0819189 A2 BRPI0819189 A2 BR PI0819189A2 BR PI0819189 A BRPI0819189 A BR PI0819189A BR PI0819189 A2 BRPI0819189 A2 BR PI0819189A2
Authority
BR
Brazil
Prior art keywords
gestagen
estrogen
vehicles
combination
pharmaceutically acceptable
Prior art date
Application number
BRPI0819189-1A
Other languages
English (en)
Inventor
Sabine Fricke
Manuela Pfeifer
Claus Claussen
Ralf Ladwig
Beate Bürglen
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0819189A2 publication Critical patent/BRPI0819189A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
BRPI0819189-1A 2007-11-05 2008-10-22 Uso de um gestagênio em combinação com estrogênio e um ou mais excipientes/veículos farmaceuticamente aceitáveis para a contracepção oral livre de lactose. BRPI0819189A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07021465A EP2055306A1 (de) 2007-11-05 2007-11-05 Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption
PCT/EP2008/008900 WO2009059690A1 (de) 2007-11-05 2008-10-22 Verwendung eines gestagens in kombination mit einem estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/ trägern zur laktosefreien oralen kontrazeption

Publications (1)

Publication Number Publication Date
BRPI0819189A2 true BRPI0819189A2 (pt) 2015-05-26

Family

ID=39016019

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819189-1A BRPI0819189A2 (pt) 2007-11-05 2008-10-22 Uso de um gestagênio em combinação com estrogênio e um ou mais excipientes/veículos farmaceuticamente aceitáveis para a contracepção oral livre de lactose.

Country Status (31)

Country Link
EP (3) EP2055306A1 (pt)
JP (1) JP2011502136A (pt)
KR (1) KR20100103794A (pt)
CN (1) CN101848716B (pt)
AR (1) AR069195A1 (pt)
AT (1) AT12800U1 (pt)
AU (1) AU2008324549A1 (pt)
BR (1) BRPI0819189A2 (pt)
CA (1) CA2704523A1 (pt)
CO (1) CO6270329A2 (pt)
CR (1) CR11413A (pt)
DE (1) DE202007019049U1 (pt)
DK (1) DK2217243T3 (pt)
DO (1) DOP2010000130A (pt)
EA (1) EA201000749A1 (pt)
EC (1) ECSP10010152A (pt)
ES (1) ES2511841T3 (pt)
HK (1) HK1145289A1 (pt)
HR (1) HRP20140962T1 (pt)
IL (1) IL205349A0 (pt)
MX (1) MX2010004975A (pt)
NZ (1) NZ585065A (pt)
PA (1) PA8803001A1 (pt)
PE (1) PE20091020A1 (pt)
PL (1) PL2217243T3 (pt)
PT (1) PT2217243E (pt)
SG (1) SG188118A1 (pt)
TW (1) TW200936142A (pt)
UY (1) UY31454A1 (pt)
WO (1) WO2009059690A1 (pt)
ZA (1) ZA201004024B (pt)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
JPH1171268A (ja) * 1997-08-28 1999-03-16 Kayaku:Kk 性ホルモン含有錠剤
CA2260673A1 (en) 1999-02-04 2000-08-04 Natrel Inc. A process for making a lactose-free milk without negatively affecting the organoleptic properties thereof; and milk so processed
DE10043846A1 (de) * 2000-09-04 2002-04-04 Jenapharm Gmbh 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
AU2004275470B2 (en) 2003-09-29 2010-12-02 Novo Nordisk Health Care Ag Improved stability of progestogen formulations
WO2005030175A1 (en) 2003-09-29 2005-04-07 Novo Nordisk Femcare Ag Hrt formulations
CN1672685A (zh) * 2004-03-26 2005-09-28 董可娟 一种新的避孕药物
DE102004019406A1 (de) * 2004-04-19 2005-11-03 Schering Ag 17α-Fluorsteroide
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026670A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
EP1690543A1 (de) * 2005-02-15 2006-08-16 Schering AG Pharmazeutisches Präparat zur Kontrazeption
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest

Also Published As

Publication number Publication date
DK2217243T3 (da) 2014-10-20
CN101848716B (zh) 2012-11-28
CN101848716A (zh) 2010-09-29
EA201000749A1 (ru) 2010-12-30
AT12800U1 (de) 2012-11-15
CR11413A (es) 2010-06-17
PE20091020A1 (es) 2009-08-15
EP2217243B1 (de) 2014-08-06
HRP20140962T1 (hr) 2014-12-05
CO6270329A2 (es) 2011-04-20
PL2217243T3 (pl) 2014-12-31
AR069195A1 (es) 2010-01-06
ECSP10010152A (es) 2010-06-29
UY31454A1 (es) 2009-05-29
DE202007019049U8 (de) 2010-09-30
ZA201004024B (en) 2012-11-28
WO2009059690A1 (de) 2009-05-14
SG188118A1 (en) 2013-03-28
IL205349A0 (en) 2010-12-30
DE202007019049U1 (de) 2010-05-12
HK1145289A1 (en) 2011-04-15
DOP2010000130A (es) 2010-07-31
PA8803001A1 (es) 2009-06-23
ES2511841T3 (es) 2014-10-23
EP2217243A1 (de) 2010-08-18
KR20100103794A (ko) 2010-09-28
EP2774614A1 (de) 2014-09-10
NZ585065A (en) 2012-06-29
MX2010004975A (es) 2010-05-24
CA2704523A1 (en) 2009-05-14
AU2008324549A1 (en) 2009-05-14
PT2217243E (pt) 2014-09-24
TW200936142A (en) 2009-09-01
EP2055306A1 (de) 2009-05-06
JP2011502136A (ja) 2011-01-20

Similar Documents

Publication Publication Date Title
USD584416S1 (en) Knee joint bandage
EP1828223A4 (en) Novel betulin derivatives, their preparation and their use
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
BR112012001353A2 (pt) anel vaginal, e, métodos para fabricar um anel vaginal e para dispensar um ou mais ingredientes farmaceuticamente ativos
IL180238A0 (en) Progesterone receptor antagonist contraceptive regimens and kits
DK2066325T3 (da) Farmaceutiske sammensætninger af aripiprazol
MX2010004353A (es) Combinación anticonceptiva oral entiemética.
BRPI0721148A2 (pt) Nanopartículas magnéticas para aplicação em hipertermia, preparação destas e uso de construtos apresentando aplicação farmacológica.
DE112005000439B8 (de) Brennstoffzellensystem und Fahrzeug, welches mit demselben ausgerüstet ist
DE602005020694D1 (de) Pharmazeutische zusammensetzung mit drospirenon und ethinylöstradiol
CL2007001961A1 (es) Composicion farmaceutica que contiene a) 2,0 mg de dienogest y 0,015 mg de etinilestradiol y (6s)-5-metil-tetrahidrofolato y uno o mas excipiente/vehiculos; kit; uso para la anticoncepcion femeneina y reducir el riesgo d malformaciones congenitas debidas a la falta de folato en el embarazo.
ZA200705495B (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
BRPI0819189A2 (pt) Uso de um gestagênio em combinação com estrogênio e um ou mais excipientes/veículos farmaceuticamente aceitáveis para a contracepção oral livre de lactose.
CL2008000999A1 (es) Composicion farmaceutica que comprende drospirenona y 17beta estradiol; kit farmaceutico que comprende a dicha composicion, util para terapia hormonal y contracepcion en mujeres.
ZA200707912B (en) Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol
AU319033S (en) Armrest for folding chair
WO2006069182A3 (en) THIENOISOQUINOLINE-PHENYLSULFONAMIDES AND THEIR USE AS ER-NFkB INHIBITORS
ATE432714T1 (de) Perorale arzneiform mit dienogest und ethinylestradiol zur kontrazeption
IL184376A0 (en) Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
任秀珍 et al. A Study of Stereotypes in Intercultural Communication
Borgen Bridging the gap?: the spiritual revolution and Trinity United Methodist Church in Austin, Texas
葛新飞 et al. A Tiger and Three Litte Rabbits
ES1063855Y (es) "asiento para uso higienico"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.